Consumer willingness to pay for a hypothetical Zika vaccine in Brazil and the implications
Background: Zika virus is a newly emerging infection, associated with increasingly large outbreaks especially in tropical countries such as Brazil. A future Zika vaccine can contribute to decreasing the number of cases and associated complications. Information about consumers' willingness to pa...
Gespeichert in:
| Veröffentlicht in: | Expert review of pharmacoeconomics & outcomes research 2019-07, Vol.19 (4), p.473-482 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 482 |
|---|---|
| container_issue | 4 |
| container_start_page | 473 |
| container_title | Expert review of pharmacoeconomics & outcomes research |
| container_volume | 19 |
| creator | Muniz Júnior, Roberto Lúcio Godói, Isabella Piassi Reis, Edna Afonso Garcia, Marina Morgado Guerra-Júnior, Augusto Afonso Godman, Brian Ruas, Cristina Mariano |
| description | Background: Zika virus is a newly emerging infection, associated with increasingly large outbreaks especially in tropical countries such as Brazil. A future Zika vaccine can contribute to decreasing the number of cases and associated complications. Information about consumers' willingness to pay (WTP) for a hypothetical Zika vaccine can help price setting discussions in the future in Brazil, starting with the private market. Methods: A cross-sectional study conducted among residents of Minas Gerais, Brazil, regarding their WTP for a hypothetical Zika Vaccine. The mean effective protection was 80%, with the possibility of some local and systemic side- effects. Results: 517 people were interviewed. However, 28 would not be vaccinated even if the vaccine was free. Most of the resultant interviewees (489) were female (58.2%), had completed high school (49.7%), were employed (71.2%), had private health insurance (52.7%), and did not have Zika (96.9%). The median individual maximum WTP for this hypothetical Zika vaccine (one dose) was US$31.34 (BRL100.00). Conclusion: Such discussions regarding WTP can contribute to decision-making about prices once a Zika vaccine becomes available in Brazil alongside other ongoing programs to control the virus. |
| doi_str_mv | 10.1080/14737167.2019.1552136 |
| format | Article |
| fullrecord | <record><control><sourceid>pubmed_D8T</sourceid><recordid>TN_cdi_swepub_primary_oai_swepub_ki_se_483935</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>30468095</sourcerecordid><originalsourceid>FETCH-LOGICAL-c451t-5c4f4c1b2f26e2f2f7ce33e09a94ffc1f8e238fd5496af78de61fe657711a7bd3</originalsourceid><addsrcrecordid>eNp9kM1OAyEURonR2Fp9BA0vMBUGGGZ2auNf0sSNbrohlAGLnYEJTG3Gp5emrUs3996Q830kB4BrjKYYlegWU044Lvg0R7iaYsZyTIoTMMac0qwkvDpNd2KyHTQCFzF-IURoxdg5GBFEixJVbAwWM-_iptUBbm3TWPfpdIyw97CTAzQ-QAlXQ-f7le6tkg1c2LWE31Ip6zS0Dj4E-WMbKF0NEwNt2zWJ621qvQRnRjZRXx32BHw8Pb7PXrL52_Pr7H6eKcpwnzFFDVV4mZu80GkYrjQhGlWyosYobEqdk9LUjFaFNLysdYGNLhjnGEu-rMkEZPveuNXdZim6YFsZBuGlFYendbq0oCWpCEs82_Mq-BiDNn8JjMTOrTi6FTu34uA25W72udTY6vovdZSZgLs9YF0y18qtD00tejk0PpggnbJRkP__-AWHEYrQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Consumer willingness to pay for a hypothetical Zika vaccine in Brazil and the implications</title><source>SWEPUB Freely available online</source><creator>Muniz Júnior, Roberto Lúcio ; Godói, Isabella Piassi ; Reis, Edna Afonso ; Garcia, Marina Morgado ; Guerra-Júnior, Augusto Afonso ; Godman, Brian ; Ruas, Cristina Mariano</creator><creatorcontrib>Muniz Júnior, Roberto Lúcio ; Godói, Isabella Piassi ; Reis, Edna Afonso ; Garcia, Marina Morgado ; Guerra-Júnior, Augusto Afonso ; Godman, Brian ; Ruas, Cristina Mariano</creatorcontrib><description>Background: Zika virus is a newly emerging infection, associated with increasingly large outbreaks especially in tropical countries such as Brazil. A future Zika vaccine can contribute to decreasing the number of cases and associated complications. Information about consumers' willingness to pay (WTP) for a hypothetical Zika vaccine can help price setting discussions in the future in Brazil, starting with the private market. Methods: A cross-sectional study conducted among residents of Minas Gerais, Brazil, regarding their WTP for a hypothetical Zika Vaccine. The mean effective protection was 80%, with the possibility of some local and systemic side- effects. Results: 517 people were interviewed. However, 28 would not be vaccinated even if the vaccine was free. Most of the resultant interviewees (489) were female (58.2%), had completed high school (49.7%), were employed (71.2%), had private health insurance (52.7%), and did not have Zika (96.9%). The median individual maximum WTP for this hypothetical Zika vaccine (one dose) was US$31.34 (BRL100.00). Conclusion: Such discussions regarding WTP can contribute to decision-making about prices once a Zika vaccine becomes available in Brazil alongside other ongoing programs to control the virus.</description><identifier>ISSN: 1473-7167</identifier><identifier>EISSN: 1744-8379</identifier><identifier>DOI: 10.1080/14737167.2019.1552136</identifier><identifier>PMID: 30468095</identifier><language>eng</language><publisher>England: Taylor & Francis</publisher><subject>Adult ; Arbovirosis ; Brazil ; contingent valuation ; Cross-Sectional Studies ; Decision Making ; Female ; Financing, Personal - statistics & numerical data ; Humans ; Male ; Middle Aged ; Patient Acceptance of Health Care - statistics & numerical data ; reimbursement ; Surveys and Questionnaires ; vaccine ; Viral Vaccines - administration & dosage ; Viral Vaccines - adverse effects ; Viral Vaccines - economics ; willingness to pay ; Young Adult ; Zika ; Zika Virus Infection - economics ; Zika Virus Infection - prevention & control</subject><ispartof>Expert review of pharmacoeconomics & outcomes research, 2019-07, Vol.19 (4), p.473-482</ispartof><rights>2018 Informa UK Limited, trading as Taylor & Francis Group 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c451t-5c4f4c1b2f26e2f2f7ce33e09a94ffc1f8e238fd5496af78de61fe657711a7bd3</citedby><cites>FETCH-LOGICAL-c451t-5c4f4c1b2f26e2f2f7ce33e09a94ffc1f8e238fd5496af78de61fe657711a7bd3</cites><orcidid>0000-0001-6539-6972 ; 0000-0003-0275-8416 ; 0000-0001-5256-0577 ; 0000-0002-0568-6625 ; 0000-0003-1465-9167</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,550,776,881</link.rule.ids><linktorsrc>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:141720668$$EView_record_in_Swedish_Publication_Index_(SWEPUB)$$FView_record_in_$$GSwedish_Publication_Index_(SWEPUB)$$Hfree_for_read</linktorsrc><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30468095$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:141720668$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Muniz Júnior, Roberto Lúcio</creatorcontrib><creatorcontrib>Godói, Isabella Piassi</creatorcontrib><creatorcontrib>Reis, Edna Afonso</creatorcontrib><creatorcontrib>Garcia, Marina Morgado</creatorcontrib><creatorcontrib>Guerra-Júnior, Augusto Afonso</creatorcontrib><creatorcontrib>Godman, Brian</creatorcontrib><creatorcontrib>Ruas, Cristina Mariano</creatorcontrib><title>Consumer willingness to pay for a hypothetical Zika vaccine in Brazil and the implications</title><title>Expert review of pharmacoeconomics & outcomes research</title><addtitle>Expert Rev Pharmacoecon Outcomes Res</addtitle><description>Background: Zika virus is a newly emerging infection, associated with increasingly large outbreaks especially in tropical countries such as Brazil. A future Zika vaccine can contribute to decreasing the number of cases and associated complications. Information about consumers' willingness to pay (WTP) for a hypothetical Zika vaccine can help price setting discussions in the future in Brazil, starting with the private market. Methods: A cross-sectional study conducted among residents of Minas Gerais, Brazil, regarding their WTP for a hypothetical Zika Vaccine. The mean effective protection was 80%, with the possibility of some local and systemic side- effects. Results: 517 people were interviewed. However, 28 would not be vaccinated even if the vaccine was free. Most of the resultant interviewees (489) were female (58.2%), had completed high school (49.7%), were employed (71.2%), had private health insurance (52.7%), and did not have Zika (96.9%). The median individual maximum WTP for this hypothetical Zika vaccine (one dose) was US$31.34 (BRL100.00). Conclusion: Such discussions regarding WTP can contribute to decision-making about prices once a Zika vaccine becomes available in Brazil alongside other ongoing programs to control the virus.</description><subject>Adult</subject><subject>Arbovirosis</subject><subject>Brazil</subject><subject>contingent valuation</subject><subject>Cross-Sectional Studies</subject><subject>Decision Making</subject><subject>Female</subject><subject>Financing, Personal - statistics & numerical data</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Patient Acceptance of Health Care - statistics & numerical data</subject><subject>reimbursement</subject><subject>Surveys and Questionnaires</subject><subject>vaccine</subject><subject>Viral Vaccines - administration & dosage</subject><subject>Viral Vaccines - adverse effects</subject><subject>Viral Vaccines - economics</subject><subject>willingness to pay</subject><subject>Young Adult</subject><subject>Zika</subject><subject>Zika Virus Infection - economics</subject><subject>Zika Virus Infection - prevention & control</subject><issn>1473-7167</issn><issn>1744-8379</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>D8T</sourceid><recordid>eNp9kM1OAyEURonR2Fp9BA0vMBUGGGZ2auNf0sSNbrohlAGLnYEJTG3Gp5emrUs3996Q830kB4BrjKYYlegWU044Lvg0R7iaYsZyTIoTMMac0qwkvDpNd2KyHTQCFzF-IURoxdg5GBFEixJVbAwWM-_iptUBbm3TWPfpdIyw97CTAzQ-QAlXQ-f7le6tkg1c2LWE31Ip6zS0Dj4E-WMbKF0NEwNt2zWJ621qvQRnRjZRXx32BHw8Pb7PXrL52_Pr7H6eKcpwnzFFDVV4mZu80GkYrjQhGlWyosYobEqdk9LUjFaFNLysdYGNLhjnGEu-rMkEZPveuNXdZim6YFsZBuGlFYendbq0oCWpCEs82_Mq-BiDNn8JjMTOrTi6FTu34uA25W72udTY6vovdZSZgLs9YF0y18qtD00tejk0PpggnbJRkP__-AWHEYrQ</recordid><startdate>20190704</startdate><enddate>20190704</enddate><creator>Muniz Júnior, Roberto Lúcio</creator><creator>Godói, Isabella Piassi</creator><creator>Reis, Edna Afonso</creator><creator>Garcia, Marina Morgado</creator><creator>Guerra-Júnior, Augusto Afonso</creator><creator>Godman, Brian</creator><creator>Ruas, Cristina Mariano</creator><general>Taylor & Francis</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>ADTPV</scope><scope>AOWAS</scope><scope>D8T</scope><scope>ZZAVC</scope><orcidid>https://orcid.org/0000-0001-6539-6972</orcidid><orcidid>https://orcid.org/0000-0003-0275-8416</orcidid><orcidid>https://orcid.org/0000-0001-5256-0577</orcidid><orcidid>https://orcid.org/0000-0002-0568-6625</orcidid><orcidid>https://orcid.org/0000-0003-1465-9167</orcidid></search><sort><creationdate>20190704</creationdate><title>Consumer willingness to pay for a hypothetical Zika vaccine in Brazil and the implications</title><author>Muniz Júnior, Roberto Lúcio ; Godói, Isabella Piassi ; Reis, Edna Afonso ; Garcia, Marina Morgado ; Guerra-Júnior, Augusto Afonso ; Godman, Brian ; Ruas, Cristina Mariano</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c451t-5c4f4c1b2f26e2f2f7ce33e09a94ffc1f8e238fd5496af78de61fe657711a7bd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Adult</topic><topic>Arbovirosis</topic><topic>Brazil</topic><topic>contingent valuation</topic><topic>Cross-Sectional Studies</topic><topic>Decision Making</topic><topic>Female</topic><topic>Financing, Personal - statistics & numerical data</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Patient Acceptance of Health Care - statistics & numerical data</topic><topic>reimbursement</topic><topic>Surveys and Questionnaires</topic><topic>vaccine</topic><topic>Viral Vaccines - administration & dosage</topic><topic>Viral Vaccines - adverse effects</topic><topic>Viral Vaccines - economics</topic><topic>willingness to pay</topic><topic>Young Adult</topic><topic>Zika</topic><topic>Zika Virus Infection - economics</topic><topic>Zika Virus Infection - prevention & control</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Muniz Júnior, Roberto Lúcio</creatorcontrib><creatorcontrib>Godói, Isabella Piassi</creatorcontrib><creatorcontrib>Reis, Edna Afonso</creatorcontrib><creatorcontrib>Garcia, Marina Morgado</creatorcontrib><creatorcontrib>Guerra-Júnior, Augusto Afonso</creatorcontrib><creatorcontrib>Godman, Brian</creatorcontrib><creatorcontrib>Ruas, Cristina Mariano</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>SwePub</collection><collection>SwePub Articles</collection><collection>SWEPUB Freely available online</collection><collection>SwePub Articles full text</collection><jtitle>Expert review of pharmacoeconomics & outcomes research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Muniz Júnior, Roberto Lúcio</au><au>Godói, Isabella Piassi</au><au>Reis, Edna Afonso</au><au>Garcia, Marina Morgado</au><au>Guerra-Júnior, Augusto Afonso</au><au>Godman, Brian</au><au>Ruas, Cristina Mariano</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Consumer willingness to pay for a hypothetical Zika vaccine in Brazil and the implications</atitle><jtitle>Expert review of pharmacoeconomics & outcomes research</jtitle><addtitle>Expert Rev Pharmacoecon Outcomes Res</addtitle><date>2019-07-04</date><risdate>2019</risdate><volume>19</volume><issue>4</issue><spage>473</spage><epage>482</epage><pages>473-482</pages><issn>1473-7167</issn><eissn>1744-8379</eissn><abstract>Background: Zika virus is a newly emerging infection, associated with increasingly large outbreaks especially in tropical countries such as Brazil. A future Zika vaccine can contribute to decreasing the number of cases and associated complications. Information about consumers' willingness to pay (WTP) for a hypothetical Zika vaccine can help price setting discussions in the future in Brazil, starting with the private market. Methods: A cross-sectional study conducted among residents of Minas Gerais, Brazil, regarding their WTP for a hypothetical Zika Vaccine. The mean effective protection was 80%, with the possibility of some local and systemic side- effects. Results: 517 people were interviewed. However, 28 would not be vaccinated even if the vaccine was free. Most of the resultant interviewees (489) were female (58.2%), had completed high school (49.7%), were employed (71.2%), had private health insurance (52.7%), and did not have Zika (96.9%). The median individual maximum WTP for this hypothetical Zika vaccine (one dose) was US$31.34 (BRL100.00). Conclusion: Such discussions regarding WTP can contribute to decision-making about prices once a Zika vaccine becomes available in Brazil alongside other ongoing programs to control the virus.</abstract><cop>England</cop><pub>Taylor & Francis</pub><pmid>30468095</pmid><doi>10.1080/14737167.2019.1552136</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0001-6539-6972</orcidid><orcidid>https://orcid.org/0000-0003-0275-8416</orcidid><orcidid>https://orcid.org/0000-0001-5256-0577</orcidid><orcidid>https://orcid.org/0000-0002-0568-6625</orcidid><orcidid>https://orcid.org/0000-0003-1465-9167</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | ISSN: 1473-7167 |
| ispartof | Expert review of pharmacoeconomics & outcomes research, 2019-07, Vol.19 (4), p.473-482 |
| issn | 1473-7167 1744-8379 |
| language | eng |
| recordid | cdi_swepub_primary_oai_swepub_ki_se_483935 |
| source | SWEPUB Freely available online |
| subjects | Adult Arbovirosis Brazil contingent valuation Cross-Sectional Studies Decision Making Female Financing, Personal - statistics & numerical data Humans Male Middle Aged Patient Acceptance of Health Care - statistics & numerical data reimbursement Surveys and Questionnaires vaccine Viral Vaccines - administration & dosage Viral Vaccines - adverse effects Viral Vaccines - economics willingness to pay Young Adult Zika Zika Virus Infection - economics Zika Virus Infection - prevention & control |
| title | Consumer willingness to pay for a hypothetical Zika vaccine in Brazil and the implications |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T21%3A53%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_D8T&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Consumer%20willingness%20to%20pay%20for%20a%20hypothetical%20Zika%20vaccine%20in%20Brazil%20and%20the%20implications&rft.jtitle=Expert%20review%20of%20pharmacoeconomics%20&%20outcomes%20research&rft.au=Muniz%20J%C3%BAnior,%20Roberto%20L%C3%BAcio&rft.date=2019-07-04&rft.volume=19&rft.issue=4&rft.spage=473&rft.epage=482&rft.pages=473-482&rft.issn=1473-7167&rft.eissn=1744-8379&rft_id=info:doi/10.1080/14737167.2019.1552136&rft_dat=%3Cpubmed_D8T%3E30468095%3C/pubmed_D8T%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/30468095&rfr_iscdi=true |